Gut microbiota: a potential new territory for drug targeting - PubMed (original) (raw)
Review
doi: 10.1038/nrd2505.
Affiliations
- PMID: 18239669
- DOI: 10.1038/nrd2505
Review
Gut microbiota: a potential new territory for drug targeting
Wei Jia et al. Nat Rev Drug Discov. 2008 Feb.
Abstract
The significant involvement of the gut microbiota in human health and disease suggests that manipulation of commensal microbial composition through combinations of antibiotics, probiotics and prebiotics could be a novel therapeutic approach. A systems perspective is needed to help understand the complex host-bacteria interactions and their association with pathophysiological phenotypes so that alterations in the composition of the gut microbiota in disease states can be reversed. In this article, we describe the therapeutic rationale and potential for targeting the gut microbiota, and discuss strategies and systems-oriented technologies for achieving this goal.
Similar articles
- Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function.
Sanz Y, De Palma G. Sanz Y, et al. Int Rev Immunol. 2009;28(6):397-413. doi: 10.3109/08830180903215613. Int Rev Immunol. 2009. PMID: 19954356 Review. - Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function.
Kanauchi O, Andoh A, Mitsuyama K. Kanauchi O, et al. J Agric Food Chem. 2013 Oct 23;61(42):9977-83. doi: 10.1021/jf402441f. Epub 2013 Oct 15. J Agric Food Chem. 2013. PMID: 24070265 Review. - The effect of probiotics and gut microbiota on Th17 cells.
Tanabe S. Tanabe S. Int Rev Immunol. 2013 Oct-Dec;32(5-6):511-25. doi: 10.3109/08830185.2013.839665. Epub 2013 Oct 4. Int Rev Immunol. 2013. PMID: 24094077 Review. - Influence of functional food components on gut health.
Wan MLY, Ling KH, El-Nezami H, Wang MF. Wan MLY, et al. Crit Rev Food Sci Nutr. 2019;59(12):1927-1936. doi: 10.1080/10408398.2018.1433629. Epub 2018 Feb 23. Crit Rev Food Sci Nutr. 2019. PMID: 29381385 Review. - Targeting gut microbiota as a possible therapy for diabetes.
He C, Shan Y, Song W. He C, et al. Nutr Res. 2015 May;35(5):361-7. doi: 10.1016/j.nutres.2015.03.002. Epub 2015 Mar 14. Nutr Res. 2015. PMID: 25818484 Review.
Cited by
- 5-aminosalicylic acid alleviates colitis and protects intestinal barrier function by modulating gut microbiota in mice.
Wang J, Wang X, Jiang M, Lang T, Wan L, Dai J. Wang J, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct 1. doi: 10.1007/s00210-024-03485-x. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39352537 - Intestinal and hepatic benefits of BBR-EVO on DSS-induced experimental colitis in mice.
Wang W, Han Y, Yin W, Wang Q, Wu Y, Du M. Wang W, et al. Front Microbiol. 2024 Sep 4;15:1428327. doi: 10.3389/fmicb.2024.1428327. eCollection 2024. Front Microbiol. 2024. PMID: 39296302 Free PMC article. - Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profiling.
Majzoub ME, Luu LDW, Haifer C, Paramsothy S, Borody TJ, Leong RW, Thomas T, Kaakoush NO. Majzoub ME, et al. mSystems. 2024 Sep 17;9(9):e0074624. doi: 10.1128/msystems.00746-24. Epub 2024 Aug 13. mSystems. 2024. PMID: 39136455 Free PMC article. - Ingesting yeast extract causes excitation of neurogenic and myogenic colonic motor patterns in the rat.
Li H, Ji Y, Luo H, Huizinga JD, Chen JH. Li H, et al. J Cell Mol Med. 2024 May;28(10):e18343. doi: 10.1111/jcmm.18343. J Cell Mol Med. 2024. PMID: 38760903 Free PMC article. - Efficacy and Safety of WCFA19 (Weissella confusa WIKIM51) in Reducing Body Fat in Overweight and Obese Adults.
Sun H, Shin J, Kim MJ, Bae S, Lee ND, Yoo B. Sun H, et al. J Clin Med. 2024 Apr 26;13(9):2559. doi: 10.3390/jcm13092559. J Clin Med. 2024. PMID: 38731087 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources